Chemed (CHE +3.9%) moves higher despite missing estimates on its Q4 report yesterday. Net income rose 14% Y/Y, weathering a drop in operating income from its Vitas hospice unit as its Roto-Rooter plumbing business offset the decline with a 28% jump in profit. The company also raises FY12 guidance, now expecting to earn $5.35 - $5.55 per share, above Street expectations of $5.27.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs